ID   MCF-7D3Res
AC   CVCL_2Z98
DR   cancercelllines; CVCL_2Z98
DR   Wikidata; Q54904405
RX   PubMed=8593782;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI:27300; Vitamin D.
CC   Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 14
//
RX   PubMed=8593782; DOI=10.1210/endo.137.2.8593782;
RA   Narvaez C.J., Vanweelden K., Byrne I., Welsh J.;
RT   "Characterization of a vitamin D3-resistant MCF-7 cell line.";
RL   Endocrinology 137:400-409(1996).
//